FDA issued a Warning Letter to Bedford Pharmacy on 5/18/2016 for a previous inspection.
483 Mytilini Enterprises dba Bedford Pharmacy Aug 2017

483 Mytilini Enterprises dba Bedford Pharmacy Aug 2017

John Mistler FDA$119.00 - Available Now

FDA investigators audited the Mytilini Enterprises dba Bedford Pharmacy - Bedford, NH, United States facility and issued inspectional observations (via FDA 483) on 17 Aug 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 17 Aug 2017
  • Location: Bedford, United States
  • FEI: 3003687986
Add To Cart